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Microtiter plate methods are commonly used for biofilm assessment. However, results obtained 
with these methods have often been difficult to reproduce. Hence, it is important to obtain a better 
understanding of the repeatability and reproducibility of these methods. An interlaboratory study 
was performed in five different laboratories to evaluate the reproducibility and responsiveness of 
three methods to quantify Staphylococcus aureus biofilm formation in 96‑well microtiter plates: 
crystal violet, resazurin, and plate counts. An inter‑lab protocol was developed for the study. The 
protocol was separated into three steps: biofilm growth, biofilm challenge, biofilm assessment. For 
control experiments participants performed the growth and assessment steps only. For treatment 
experiments, all three steps were performed and the efficacy of sodium hypochlorite (NaOCl) in killing 
S. aureus biofilms was evaluated. In control experiments, on the  log10‑scale, the reproducibility SD 
 (SR) was 0.44 for crystal violet, 0.53 for resazurin, and 0.92 for the plate counts. In the treatment 
experiments, plate counts had the best responsiveness to different levels of efficacy and also the best 
reproducibility with respect to responsiveness (Slope/SR = 1.02), making it the more reliable method 
to use in an antimicrobial efficacy test. This study showed that the microtiter plate is a versatile and 
easy‑to‑use biofilm reactor, which exhibits good repeatability and reproducibility for different types of 
assessment methods, as long as a suitable experimental design and statistical analysis is applied.
Abbreviations
Mixed effects ANOVA  Statistical process for separating the variability of a group of observations into 
assignable sources and performing significance tests.
Error  Represents variability attributable to well-to-well differences.
Day  Represents variability attributable to day-to-day differences e.g., different inoculum, 
temperature, humidity, etc.
Lab  Represents variability attributable to lab-to-lab differences e.g., different technicians, 
equipment, climate, etc.
Repeatability  Represents the variability within each lab (error + day).
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Reproducibility  Represents the variability among labs (total = error + day + lab).
Responsiveness  Sensitivity of a method; ability of a method to detect important changes in an anti-
microbial’s efficacy (e.g., due to changes in concentration or contact time)
The lack of reproducibility among published studies has become one of the bigger concerns across different 
scientific research areas and biofilm research is certainly no  exception1,2. This is due to many different factors, 
including selective or incomplete reporting of the experiments performed and lack of robust  methods3,4.
Microtiter plate-based methods are some of the more widely used methods in biofilm research. They are 
inexpensive, easy to use, versatile and adaptable for high-throughput  screening5,6. However, little is known about 
their repeatability (within lab variation) and there are currently no reports on their reproducibility (among lab 
variation)7,8. The microtiter plate is a batch system in which the biofilm is grown in a small volume and then 
assessed using a variety of methods. Most assessment methods rely on the use of dyes (e.g. crystal violet and 
resazurin) to stain the biofilm or some of its components; colony forming unit (CFU) counts are also  used9. The 
variety of assessment methods available has led to many possible applications for microtiter plate-based methods 
such as antimicrobial compound screening, assessing the biofilm forming ability of different microorganisms, 
and evaluating the effect of various factors on biofilm  formation10–13.
Considering the widespread use of microtiter plate methods in the field, the evaluation of their reproducibil-
ity is of a clear interest to the biofilm community as it would provide an insight into the potential of microtiter 
plates for standardisation, which could be useful for antimicrobial screening  tests14. Additionally, it could serve 
as a starting point for making microtiter plate data comparable across research groups and also help us better 
understand what factors might affect the performance of microtiter plate experiments.
Efforts have started to improve the reporting of microtiter plate experiments, through the implementation 
of minimum information guidelines on reporting biofilm experiments (www. miabie. org)15,16. Moreover, the 
repeatability and reproducibility of methods using other biofilm reactors have been evaluated, which can serve 
as a reference for evaluating microtiter plate methods. Devices such as the MBEC, the CDC Biofilm Reactor 
and Drip Flow Biofilm Reactor were assessed through interlaboratory studies, where 6–8 different laboratories 
perform the same  protocol17–19. As a result of these tests, several standard methods for the use of these devices 
in antimicrobial testing have been  approved20–22. In order for a protocol to be accepted as a standard method, 
the standard deviation (SD) of the reproducibility needs to be “small”, often determined by standard methods 
societies, e.g., American Society for Testing and Materials (ASTM).
In the present study, we aim to evaluate the reproducibility and responsiveness of three different biofilm 
assessment methods (crystal violet, resazurin and plate counts) applied to microtiter plates through a ring trial, 
performed across five different laboratories located in the US and Europe. This paper reports on the repeatability 
in each lab and the reproducibility across different labs of each of these three assessment methods. Additionally, 
it evaluates the responsiveness of these methods in assessing an antimicrobial efficacy test.
Materials and methods
The description provided in this “Materials and methods” section complies with the recently-published guideline 
on reporting spectrophotometric and fluorometric methods to assess biofilms in  microplates16.
Study design. The ring trial investigated three different biofilm assessment methods in flat bottom, 
untreated, polystyrene, 96-well microtiter plates: plate counts, resazurin and crystal violet. Six laboratories ini-
tially took part and are identified by numerical Lab IDs between 1 and 6. One participant from each laboratory 
performed the experiments. The participants were provided with a detailed inter-lab protocol (ILP) and a list 
of supplies (S1 supplementary information file). The protocol was tested and optimized prior to the start of 
the interlaboratory study. ILP was divided into three distinct steps: biofilm growth, biofilm challenge and bio-
film assessment. For the latter, separate protocols for each assessment method were provided. Participants were 
instructed to find closest substitute/match for materials in the supply list (S1 Supplementary Information File) 
when possible, hence there is a difference in supplier between labs.
The data collected from Lab 5 have been removed from all data analysis. An initial analysis identified their 
control data as severe outliers. Subsequent inquiries revealed that their treatment experiments data were also 
unusable due to deviations from performing the protocols and a lack of documentation. Results of control data 
analysis with Lab 5 data included can be found in S2 supplementary information file.
Biofilm growth. Staphylococcus aureus subsp. aureus (ATCC 25923) was used for the ring trial. Briefly, stocks 
were streak plated on Tryptic Soy Agar (TSA) at 37 ± 2 °C for 24 h. One or two colonies were transferred into 
15 mL Tryptic Soy Broth (TSB) and incubated at 37 ± 2 °C, 125 rpm, overnight. An aliquot was sub-inoculated 
in fresh TSB at 37 ± 2 °C, 125 rpm until exponential growth phase [OD = 0.300 (595 nm) or 7.5 ± 0.5  Log10 CFU/
mL] was achieved. This inoculum was diluted to a concentration of 5.5 ± 0.5  Log10 CFU/mL. 200 µL/well was 
transferred to a 96-well plate for biofilm formation at 37 ± 2 °C, no shaking for 24 h in a humidified incubator. 
Wells containing only TSB were used as negative controls to check for contamination. The full biofilm growth 
protocol can be found in S1 supplementary information file.
Plate reader tests. Crystal violet and resazurin require the use of plate readers and output values can vary 
greatly across different models and manufacturers. Hence, calibration curves were necessary to compare the 
outputs from different labs. For crystal violet different concentrations of the dye were added to the wells of a 
microtiter plate (starting from 0.01 g/L) and their absorbance at λ = 595 nm was measured. For resazurin, the 
participants chemically reduced resazurin into resorufin and added different concentrations to a microtiter plate 
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(starting from 5 µg/mL) and measured fluorescence at λexcitation = 560 nm; λemission = 590 nm. The detailed protocol 
can be found in S1 supplementary information file.
Control experiments. For the control experiments, only the biofilm growth and biofilm assessment parts of 
the protocol were performed. One 96-well plate was used per assessment method, per experimental day, two 
experimental days in total. Due to the nature of the methods for plate counts only 15 wells/plate were quantified, 
whereas for crystal violet and resazurin the entire plate (minus control wells) was assessed. Laboratories with 
their own in-house protocols (IHP) for the assessment methods prepared an extra plate and performed their 
own assessment protocol in parallel with the ILP used for the ring trial. For both plates the biofilm was prepared 
using the ILP biofilm growth protocol. The detailed protocols are found in the S1 Supplementary Information 
File.
Treatment experiments. For the treatment experiment, all three steps of the ILP were performed. For the bio-
film challenge step, sodium hypochlorite (NaOCl), i.e., bleach, was used to challenge the biofilm. Half of one 
96-well plate was used per method, per experimental day, with three experimental days in total. Titration tests 
were used to measure the total concentration of chlorine (Cl). The antimicrobial was then diluted to four dif-
ferent concentrations of Cl in NaOCl reported as NaOCl concentrations (1000 mg/L, 500 mg/L, 100 mg/L and 
10 mg/L) which, were added to the biofilm (200 μl/well) for 10 min and neutralised by washing twice with PBS. 
Ultra-pure water was added to the controls to account for the effect of the fluid exchange on biofilm removal. All 
concentrations were tested on the same day, 8 wells per treatment. For plate counts only 3 wells per concentra-
tion per plate were quantified, for crystal violet and resazurin 8 wells per concentration per plate were assessed. 
No IHP treatment data were generated; IHP data were generated only for control experiments. Detailed proto-
cols are found in the S1 supplementary information file.
Statistical analysis. Plate count data treatment. The colonies formed were counted on each plate, aver-
aged across plates, multiplied by the dilution factor  10d, divided by the drop volume (10 µL), multiplied by the 
total well volume (200 µL) and then converted to a log density (LD) per well using the following equation:
For the treatment experiments when no colonies were present on agar plates, a value of 0.5 CFU/well was 
assigned to a single plate at the lowest dilution counted. The antimicrobial’s effect was quantified as a log reduc-
tion (LR). A single LR value was calculated for each chlorine concentration used, for each experimental day. 
The LR is equal to the mean of the treated log density (LD) for each treatment concentration subtracted from 
the mean of the control LD.
Crystal violet and resazurin data transformation. “Raw” data collected from the plate reader tests were used to 
generate calibration curves for each method and each lab. Equations were generated for these curves by linear 
regression analysis and they were used to transform the data. Based on the regression analysis,  log10 fluorescence 
vs  log10 resorufin was chosen as the calibration curve for the resazurin data as it better fit the initial calibration 
data and allowed for better prediction for resazurin/resorufin concentrations from the later part of the study that 
fell outside the range of the calibration curve. This extrapolation occurred because the resazurin was chemically 
reduced for the calibration phase of the study making it difficult to ensure that the fluorescence values used to 
generate the calibration curve contained the values measured during the later biofilm experimentation phase. 
This extrapolation is a potential weakness of our results. In summary, “raw” fluorescence data were transformed 
to  log10 fluorescence and further transformed to  log10 resorufin concentration (µg/mL) based on the calibration 
curve equation for each lab.
For crystal violet, absorbance vs crystal violet concentration was chosen as the calibration curve. Hence, 
“raw” optical density data were transformed to crystal violet concentrations (µg/mL) based on the calibration 
curve equation for each lab. Although initial experiments were performed at a single lab to estimate the CFUs 
corresponding to crystal violet concentrations at that lab, each lab did not generate such a calibration curve, so 
it is not possible to transform the ODs or crystal violet concentrations to CFU densities.
For both methods, negative control values (wells containing TSB only, no bacteria) were not taken into con-
sideration as there were no negative controls in the plate reader test, so the calibration curves do not account 
for negative controls. Calibration curve plots and equations can be found in supplementary information file S3.
Repeatability and reproducibility assessment. To investigate the repeatability (day-to-day variability) and 
reproducibility (lab-to-lab variability) for the control data generated by the methods, the data were first 
 log10-transformed: LD for plate counts,  log10 resorufin or  log10 crystal violet concentration. A mixed effects 
ANOVA model was then fit to the log-transformed responses for each of the 3 methods separately. ‘Lab ID’ and 
‘day’ were assigned as random factors, with ‘day’ nested within ‘Lab ID’, meaning the levels of the factor ‘day’ 
are different for each lab. The model estimates the variability in the response for three different sources: error 
(well-to-well), day (day-to-day) and lab (lab-to-lab). The repeatability variance of the method is represented by 
the error + day variance. The repeatability standard deviation  (Sr) is the square root of this variance. The repro-
ducibility variance of the method is represented by the sum of all variance components and the reproducibility 
SD  (SR) is the square root of this  variance23. It is common to report the variance components as percentages of 
the “total” reproducibility variance (see e.g. ASTM E691) calculated by dividing each variance component by the 
reproducibility variance.
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For the treatment experiments, the reproducibility SD of LRs was estimated for each NaOCl concentration 
separately by fitting a mixed effects ANOVA to the LRs for each method separately with a random factor for 
Lab ID.
ILP versus IHP comparison. To evaluate the effect that the change of protocol (ILP vs IHP) had on the control 
data we fit a mixed effects ANOVA to the log responses for all 3 methods where Day and Lab ID were assigned 
as random factors and protocol was assigned as a fixed factor. The ANOVA was followed by Tukeys 95% CIs to 
determine statistical equivalence at 97.5% confidence for the median responses for ILP and IHP (CFU density 
for plate counts, resoforin concentration, and crystal violet). For the plate count method the equivalency margin 
of 0.5 logs was chosen based on previous examples in the  literature24,25. On the other hand, no previous reference 
was found for establishing an equivalency margin for resazurin and crystal violet method, so the equivalency 
margin of 0.5 log was used for these methods as well. When comparing IHP vs ILP for each of the 3 methods, 
the equivalency margin of 0.5 applied on the log scale means that differences in means of the log-transformed 
responses up to 0.5 log are negligible and not of practical importance. When antilogging, the conclusion is that 
differences up to a 70% decrease (1 − 10–0.5) or a threefold increase (100.5) in the median response for the IHP 
compared to median response for the ILP are negligible and not of practical importance.
Responsiveness assessment. To assess the responsiveness of the methods to the NaOCl treatment we con-
structed dose–response curves using the mean LR concentrations per NaOCl concentration, per day, per lab. A 
mixed effects ANOVA with a random factor for Lab ID and  Log10 NaOCl as a covariate was fit to the LRs for all 
concentrations to assess the responsiveness of the method and also to assess the reproducibility pooled across 
all concentrations.
Furthermore, a mixed effects ANOVA was performed for each NaOCl concentration separately and the 
resulting  SR values were fit by a parabola as a function of LR. To enforce our prior belief that the parabola should 
be concave, the leading term was constrained to be non-positive26. This constraint only had to be enforced for 
crystal violet data, where the leading term was set to zero.
Model assessment and software. The choice to log-transform the responses (CFU density for the plate count 
data, resorufin concentration for the resazurin data, crystal violet concentration) is crucial. Initially, for control 
and efficacy responses each of the 3 methods, the log-transform was required to satisfy the ANOVA assumptions 
of normality and constant variance. These assumptions were checked using “normal probability” and “residual 
vs fits” plots of the residuals. Just as importantly, having all responses on the log-scale made method comparisons 
straightforward. Because SDs of log responses are invariant to a change in units, here we directly compare the 
SDs from the different methods. Furthermore, because a difference in log responses such as a LR is unitless, we 
directly compare slopes and the mean LR values when assessing the responsiveness of the methods.
All statistical assessments were performed using Minitab v.18® [Minitab 18 Statistical Software (2019). State 
College, PA: Minitab, Inc. (www. minit ab. com)] Mixed Effects Models Functionality that allows the user to 
specify (as described above): the response (control or LR), fixed effects (e.g., ILP vs IHP), random effects (lab 
and day nested in lab) and covariate (e.g., time). From the full data set supplied via the link in the Supplementary 
Materials, Minitab’s Mixed Effects Model function, with the inputs just described, could be used to reproduce 
the results that we present here. Minitab was also used to generate all the figures. Horizontal jitter was applied 
to the points in the graphs to better visualise the data.
Results
Control. Interlaboratory protocol analysis. To investigate the repeatability and reproducibility of the control 
experiments for the ILP protocols, the data collected for each lab, across two experimental days, have been in-
cluded in Fig. 1. A summary of the results can be found in Table 1. From Fig. 1A and Table 1 we can see that most 
of the variability is due to lab-to-lab differences. Similar to the plate count method, the variability of resazurin 
method (Fig. 1B) and crystal violet method (Fig. 1C) is mostly due to lab-to-lab differences. The trend of the data 
is similar across all three methods (Fig. 1), meaning labs that respond lower for one method do so for the other 
two as well e.g., lab 3 has the lower values on average for all 3 methods compared to the rest of the labs. Likewise, 
the labs with higher responses for one method, have higher responses for the other methods as well e.g., lab 6.
When comparing the repeatability and reproducibility across all three methods based on the SD values in 
Table 1, the crystal violet method is most repeatable and the most reproducible of the three, followed by resazurin 
and finally the plate count method. As discussed in the Methods, it is possible to directly compare the SDs for 
the different methods in Table 1 because SDs of log responses are invariant to a change in units.
Interlaboratory protocol vs in‑house protocol. One of the questions we wanted to answer in the present study 
was whether the protocol used for the assessment method made a difference in method outcomes. For this 
purpose, some of the labs, with established in-house protocols (IHP), performed them in parallel to the ILP pro-
tocol. For the plate count method only labs 2 and 6 performed IHPs (Fig. S4.1). For the resazurin method, labs 
4 and 6 performed IHPs (Fig. S4.2) and for the crystal violet method labs 2, 4, and 6 performed IHPs (Fig. S4.3).
A summary of the statistical comparison of ILP vs IHP for each three methods is given in Table 2. For each 
method, the ILP protocol has a better (smaller) reproducibility  SR. However, the mean LDs,  log10 res and  log10 
CV between the ILP and IHP for each of the three methods were statistically significantly  equivalent27.
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Treatment. The dose response curves with respect to the LRs are shown per lab in Figs. S4.4, S4.5 and S4.6. 
The dose–response curves pooled over all labs are shown in Fig. 2.
A summary of the analysis is shown in Table 3. Based solely on the reproducibility  SR values from the table, 
crystal violet is the most reproducible method with an  SR = 0.28, followed by resazurin  (SR = 0.36) and plate 
counts  (SR = 1.79).
However, the dose–response for the crystal violet method (Fig. 2C) is quite different compared to the other 
two. Furthermore, in some instances crystal violet showed negative LR values for the treatment experiments 
(Fig. 2C and Fig. S4.6), which means that the treated biofilms had higher crystal violet concentrations than the 
side-by-side controls suggesting that there was an issue with the method despite the low  SR value. From the 
dose response relationship for each method in Table 3, the responsiveness of the method was evaluated based 
on the slope of the regression line. The larger the slope, the more responsive the method is. Hence, the plate 
count method is the most responsive of the three, and crystal violet was the least responsive. As discussed in the 
Figure 1.  Control experiment data for the ILP protocol. Along the horizontal axis are listed the lab IDs and 
the two experimental days within each lab. Horizontal jitter has been applied to better visualize data points. 
(A) Plate count—Each point in the graph is the log density (LD = log10(CFU/well)) of biofilm bacteria grown 
on a single well. (B) Resazurin—Each point in the graph is the  log10 resorufin concentration (µg/mL) of 
biofilm bacteria grown on a single well. (C) Crystal violet—Each point in the graph is the  log10 crystal violet 
concentration (µg/mL) of biofilm bacteria grown on a single well.
Table 1.  Summary of statistical analysis for the ILP control data for each method. The table shows the main 
conclusions (mean Log values ± Standard Error (SE), variance and standard deviations for repeatability and 
reproducibility) for the control data using the ILP protocols only for all participating labs, excluding lab 5. 
Recall from the glossary and methods section that the Repeatability SD is the square root of the “Day + Error” 
variance, and the Reproducibility SD is the square root of the “total variance”.
Method Mean  log10 response ± SE Units
Variance components Standard deviation
day + error Lab Repeatability Reproducibility
Plate count 7.32 ± 0.40 CFU/well 8.82% 91.18% 0.27 0.92
Resazurin 0.71 ± 0.22 µg/mL 15.89% 84.11% 0.21 0.53
Crystal Violet 1.13 ± 0.19 µg/mL 10.18% 89.82% 0.14 0.44
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Table 2.  Comparison of the ILP and IHP control data for each method. The table shows the main conclusions 
(mean  Log10 values ± Standard Error (SE), and standard deviations for repeatability and reproducibility, 
difference between means, and equivalency testing at 97.5% confidence with an equivalency margin of 0.5 logs) 
for the control experiments data using the ILP and IHP protocols.
Method Protocol Mean  log10 response ± SE Units
Standard deviation
ILP IHP ResultRepeatability Reproducibility
Plate count
ILP 8.20 ± 0.33 CFU/well 0.13 0.49
0.035 Equivalent
IHP 8.17 ± 0.42 CFU/well 0.17 0.60
Resazurin
ILP 1.15 ± 0.04 µg/mL 0.11 0.11
0.105 Equivalent
IHP 1.05 ± 0.04 µg/mL 0.16 0.16
Crystal Violet
ILP 1.42 ± 0.08 µg/mL 0.14 0.18
− 0.095 Equivalent
IHP 1.52 ± 0.23 µg/mL 0.19 0.42
Figure 2.  Dose response curves for treatment data. Each data point represents the mean LR per experimental 
day, per lab. The red curve indicates the regression line. (A) Plate count, (B) Resazurin, (C) Crystal violet.
Table 3.  Summary of the treatment data for each method. The table shows the  SR values for the LRs pooled 
over all concentrations of the NaOCl treatment when applying the ILP protocols only. In addition, the 
equation of the regression line (shown in Fig. 2) that quantifies the dose response curve for each method. The 
slope in each equation quantifies responsiveness of each method, hence the column Slope/SR is a measure of 
the reproducibility of each method relative to the responsiveness.
Method SR Equation Slope/SR
Plate count 1.79 LR = − 1.196 + 1.823Log10NaOCl 1.02
Resazurin 0.36 LR = − 1.406 + 0.3132Log10NaOCl 0.87
Crystal Violet 0.28 LR = − 0.2186 + 0.08669Log10NaOCl 0.31
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“Methods”, it is possible to directly compare the mean LRs, SDs and slopes for the different methods because 
LRs, SDs and slopes of log responses are invariant to a change in units.
The reproducibility for all three methods is further illustrated in Fig. 3. In these graphs the reproducibility 
SD was plotted as a frown shaped function of the mean LR (across all 5 labs) for each NaOCl concentration. 
This is in contrast to the reproducibility SD presented in Table 3 that was calculated by pooling the data over all 
concentrations of NaOCl. For the plate count method (Fig. 3A), a similar relationship has been found for other 
antimicrobial test methods and  micoorganisms26. Figures 3B and C show, for the first time in the literature, that 
the reproducibility SDs for resazurin and crystal violet appear to have this same frown shaped pattern. This sug-
gests that microbial LRs, whether from CFUs, resazurin or crystal violet, are most reproducible for ineffective 
and highly effective antimicrobials.
To provide a comparison between the three methods that accounts for both responsiveness and reproducibil-
ity, we divided the slope of the dose–response curve by the reproducibility  SR (Slope/SR), analogous to the signal 
to noise ratio (and inversely related to the relative standard error and the limit of quantitation)28. The higher this 
unitless value the better the method is at evaluating the effect of different concentrations of treatment. The plate 
count method performs best, even though it had the worst reproducibility SD, because of the large change in LRs 
as the concentration of NaOCl was changed (i.e., because of the steep slope). The crystal violet method performs 
the worst in spite of having the best reproducibility because of poor responsiveness; thus, in our setup it is not 
suitable for differentiating antimicrobials with different efficacy. A potential reason for this poor responsiveness 
may be a peculiar interaction noticed between the bleach, the plastic material of the microtiter plate and the 
crystal violet dye (Fig. S4.7). In follow up experiments, when bleach at different NaOCl concentrations (2% vol/
vol and 0.1% vol/vol) was added to an empty microtiter plate for 10 min and the plate was subsequently stained 
with 0.1% vol/vol crystal violet, the stain bound to the wells, despite the lack of biofilm. One reason for this could 
be that the bleach is corroding the surface of the wells and creates a rougher surface where the crystal violet can 
bind. Another possible explanation could be due to the redox reaction between crystal violet and bleach, which 
results in crystal violet losing colour. If any bleach is left behind following neutralisation then it might be affecting 
the crystal violet dye. Hence, when choosing a suitable method, it is important to take into consideration any 
chemical interactions between the antimicrobial agent, the material used to grow the biofilm and any staining 
agents used in the assessment method.
Moreover, from the dose–response curves for the plate count method in Fig. S4.4 it can be seen that for lab 
3 the differences between the 4 NaOCl concentrations are not as pronounced as for the other labs. One reason 
for this difference in response was thought to be the relationship between the starting LD of the biofilm and the 
resulting LR, as biofilms with a lower starting LD are overall easier to kill by antimicrobial  agents29. This can be 
Figure 3.  Reproducibility curves. Reproducibility SD  (SR) calculated as a function of the mean log reduction 
(LR) for all 4 concentrations of NaOCl across all 5 labs. (A) Plate count, (B) Resazurin, (C) Crystal violet.
8
Vol:.(1234567890)
Scientific Reports |        (2021) 11:13779  | https://doi.org/10.1038/s41598-021-93115-w
www.nature.com/scientificreports/
seen in the graphs in Fig. S4.8, where the Mean LR for each lab was plotted as a function of the mean control LD. 
All 4 graphs show that for labs with higher mean control LDs, the mean LR values are lower. Hence, since lab 
3 has overall lower control LD values (Fig. 1), the biofilm might be easier to kill with lower concentrations of 
NaOCl and saturation is reached, leading to no difference in LR between different treatments.
Discussion
Despite the extensive use of microtiter plate methods in biofilm research, little is known about their comparabil-
ity, limitations, repeatability, and reproducibility. Due to this lack of information data collected from microtiter 
plate methods often have little use outside of an individual study, or outside studies performed in the same 
laboratory. With this interlaboratory study we aimed to answer some of these questions: Is it possible to compare 
microtiter plate data across different labs? How repeatable and reproducible are crystal violet, resazurin and plate 
counts in microtiter plate experiments? How does the change in protocol for the assessment step affect reproduc-
ibility? How responsive and reproducible are these methods when performing an antimicrobial efficacy test?
First, our results clearly show that comparability between different labs is achievable. For the plate count 
method, this is very straightforward, however for resazurin and crystal violet extra steps and data transformations 
are necessary. Due to differences in plate reader outputs, to compare resazurin and crystal violet data across labs, 
it was imperative that each lab calculate their own calibration curves. An attempt was made to compare “raw” 
data without the use of calibration curves, and the repeatability and reproducibility were adversely affected [raw 
data available in Zenodo repository, https:// doi. org/ 10. 5281/ zenodo. 44500 73]. The implementation of calibra-
tion curves enabled us to report the data as  log10 concentration of crystal violet and resorufin, as opposed to 
the more commonly used optical density (OD) and fluorescence emission data. Use of calibration curves is not 
common practice for these methods and as such it is not possible to compare any published data from different 
research groups on these methods even if their protocols are similar or exactly the same. Hence, the way in which 
the scientific community treats and reports such data needs to change.
Once we made the data comparable, we examined how repeatable and reproducible each of these three 
assessment methods were in microtiter plates. If we focus solely on our study, the control experiment results 
showed that the crystal violet method is the most repeatable and reproducible method of the three, while plate 
counts were the least. However, previous studies on the repeatability of microtiter plate methods seem to be in 
contradiction with our results. In the study by Jorge et al. 2015, they evaluated the repeatability of the crystal 
violet, plate counts and XTT methods in assessing Pseudomonas aeruginosa biofilms. Their results showed issues 
with repeatability for all three methods, most noticeably for the crystal violet  method7. Similarly, in the study by 
Kragh et al. 2019 they report better repeatability for the plate count method when compared to crystal violet for 
24 h biofilms of P. aeruginosa8. The most probable explanation for these differences could be the way the data 
were treated. These studies do not use calibration curves for the crystal violet data and instead report them as 
OD values and they also do not log transform their plate count data. These observed differences in repeatability 
could also be due to differences in the bacterial species used, as our study was performed on S. aureus biofilms, 
not P. aeruginosa. Moreover, they could also be attributable to differences in the biofilm growth protocol and 
assessment methods protocols.
As the plate count method is extensively used in previously validated standard methods, we can compare the 
reproducibility of our ILP protocol to that observed for other biofilm growing  devices17,18,22. For example, the 
MBEC device which has been accepted as a standard method for antimicrobial testing on P. aeruginosa  biofilms20 
is a modified microtiter plate where the biofilm grows on pegs attached to the microtiter plate lid. As such the 
environment and growth conditions within the MBEC device are similar to the microtiter plate. For the MBEC 
device the ring trial results showed a control  SR = 0.67 and Mean  Log10 CFU/mm2 = 5.4817. If we convert our data 
to  Log10 CFU/  mm2, the Mean  Log10 CFU/mm2 = 5.14 and the control  SR remains the same at 0.92. Hence, our 
control data are not as reproducible as the MBEC device (Table 1). Nevertheless, acceptable repeatability and 
reproducibility SDs for plate counts from controls are < 0.5 and < 0.7,  respectively30. In our case, the plate count 
method has very repeatable control data with an SD = 0.27, but less reproducible control data with an  SR = 0.92. No 
references are available for acceptable SD values for control data from the crystal violet and resazurin methods.
To compare the reproducibility of the LRs between microtiter plates and the MBEC, we can compare the 
reproducibility curve in Fig. 3A to the similar frown shaped curve showing reproducibility for the  MBEC26,29. The 
reproducibility SD curve in Fig. 3A is higher than for the MBEC over the same range of LRs, peaking at about 
 SR = 2 for the microtiter method compared to  SR = 1.5 for the MBEC. This indicates that LRs generated from CFUs 
from the 96-well microtiter plate method are more variable than the MBEC when testing antimicrobials with a 
wide range of efficacy. One possible explanation for this could be the difference in the biofilm harvesting protocol. 
While the MBEC device relies on a mostly automated process by using sonication to remove the biofilm from the 
pegs, for the microtiter plate the biofilm is removed by scrapping each well individually, which may increase the 
chance for human error. Moreover, as the ILP protocol did not go through the ruggedness testing that the MBEC 
device and other standard methods went through, further optimisation could help improve the reproducibility 
of the  method17,31. Nonetheless, as these tests were performed for different species of bacteria, it is not certain if 
this difference in reproducibility is due to the different bacteria or the protocols used or the device itself.
Another question we wanted to explore was whether using a standardised protocol for the assessment method 
made a difference in results. For this purpose, groups with established in-house protocols (IHP) performed them 
in parallel to our ILP. For all three methods, the results showed that the mean response was statistically signifi-
cantly equivalent between the different protocols but that the reproducibility for the ILP was better (i.e., the  SR 
values for the ILP were smaller). One interesting detail to consider is that the biofilm growth protocol and the 
inoculum used was the same for both the ILP and the IHP protocols. This suggests that what contributes the most 
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to variability is how the biofilm is grown and how the inoculum is prepared, rather than how the assessment of 
the biofilm is performed, an observation that is in agreement with previous  research32.
Finally, we wanted to evaluate which assessment method would be the most appropriate to use for a treat-
ment efficacy test. For this purpose, we chose NaOCl as the antimicrobial treatment and we evaluated NaOCl 
contact killing at four different NaOCl concentrations. An initial look at the results seemed to suggest that once 
again the crystal violet method was the most reproducible and as such the better method to use. However, when 
performing treatment efficacy testing, the responsiveness of the method is crucial. Responsiveness indicates 
the ability of the method to differentiate between different concentrations of the treatment and evaluate it as a 
dose–response. The plate count method was the most responsive method of the three. Furthermore, when we 
looked at their reproducibility with respect to responsiveness, the plate count method performed the best out 
of the three. Unexpectedly, the resazurin method which measures the metabolic activity of the biofilm showed 
poor responsiveness compared to plate counts. This could be due to a high presence of viable but dormant cells 
in the treated wells or an unknown interaction of resazurin with the antimicrobial used. Another possibility is 
that the observed responsiveness of the plate counting method is artificially too high due to a large number of 
viable but non-culturable survivors on treated carriers.
In conclusion, the microtiter plate is a versatile and easy-to-use biofilm reactor which shows good repeatability 
and reproducibility for different types of assessment methods. It can also allow for comparison of data between 
different labs. However, for comparisons across labs to be possible calibration curves are essential, hence there 
needs to be a change in the way we report microtiter plate experiment data, especially for spectrophotometric 
and fluorometric type assays. This combined with more detailed reporting based on minimum information 
guidelines could add more value to results obtained from microtiter plate experiments and open the possibility 
for comparison across studies and data mining applications.
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